Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour?

Registos relacionados

• Small molecular glucokinase activators: has another new anti-diabetic therapeutic lost favour?
  Por: Rees, MG, et al.
  Publicado em: (2013)
• A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease
  Por: Rees, MG, et al.
  Publicado em: (2014)
• Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
  Por: Gloyn, A
  Publicado em: (2003)
• A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease.
  Por: Matthew G Rees, et al.
  Publicado em: (2014-01-01)
• Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes.
  Por: Gloyn, A, et al.
  Publicado em: (2002)